TG Therapeutics Inc (NASDAQ:TGTX)
| 16.44 Delayed Data As of Dec 06 |  +2.12 / +14.80%Today’s Change | 6.46 Today|||52-Week Range 35.67 | +38.97% Year-to-Date |
Latest TGTX News | Press Releases
No recent news for TG Therapeutics Inc.
Today’s Trading
| Previous close | 14.32 |
| Today’s open | 14.91 |
| Day’s range | 14.82 - 16.70 |
| Volume | 335,623 |
| Average volume (3 months) | 5,865,990 |
| Market cap | $2.1B |
Data as of 3:59pm ET, 12/06/2023
Growth & Valuation
| Earnings growth (last year) | +44.37% |
| Earnings growth (this year) | +39.41% |
| Earnings growth (next 5 years) | -57.11% |
| Revenue growth (last year) | -58.36% |
| P/E ratio | NM |
| Price/Sales | 575.19 |
| Price/Book | 34.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INDVIndivior PLC | -0.94 | -5.88% |
| ---- | ||
| CRNXCrinetics Pharmaceut... | -0.27 | -0.81% |
| ---- |
Data as of 4:00pm ET, 12/06/2023
Financials
| Next reporting date | February 27, 2024 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $2.8M |
| Annual profit (last year) | -$198.3M |
| Net profit margin | -7,121.54% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Morrisville, North Carolina |
Forecasts
